| Name | Title | Contact Details |
|---|
Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges.
WPS Health Solutions is a nationally regarded government contractor and leader in the insurance industry, serving our communities for more than 70 years. WPS has five divisions committed to delivering high-quality service to our customers. - The WPS Health Insurance division offers affordable health plans for individuals, small businesses, and large businesses, plus benefits administration. - The WPS Government Health Administrators division administers Part A and Part B Medicare benefits—services we have provided since the program`s inception—for millions of seniors in multiple states. - The WPS Military and Veterans Health division serves millions more beneficiaries who are active in the U.S. military, veterans, and their families. - The Arise Health Plan division offers high-value health plans with local service. - The EPIC Specialty Benefits division has offered voluntary non-medical benefits, such as term life, disability, dental, and vision, for more than 25 years. WPS also actively partners with non-profit organizations to help make lasting changes in the communities we serve, with an emphasis on health issues, especially for military and veterans, and women and children.
Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient`s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
Hobbs Medical Inc is a Stafford Springs, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.